Legal & General Group Portfolio holdings
Legal & General Group Plc, founded in 1836 by six lawyers in London, is a British multinational financial services company headquartered in London, renowned for its leadership in insurance, pensions, and investment management. Managing trillions in assets, the firm operates through key divisions like Legal & General Investment Management (LGIM), one of the UK’s largest asset managers, focusing on index funds, active strategies, and sustainable investing for institutional clients like pension funds. It also provides life insurance, retirement products, and general insurance, serving millions of customers with a strong emphasis on long-term financial security and infrastructure investment, such as affordable housing. With a heritage of stability and a modern push toward ESG (environmental, social, governance) principles, Legal & General remains a cornerstone of the UK financial landscape with a growing global presence.
Top Buys
| 1 |
Zoom
ZM
|
+$232M |
| 2 |
Match Group
MTCH
|
+$117M |
| 3 |
Algonquin Power & Utilities
AQN
|
+$65.4M |
| 4 |
Adobe
ADBE
|
+$53.8M |
| 5 |
KKR & Co
KKR
|
+$45.6M |
Top Sells
| 1 |
Apple
AAPL
|
+$515M |
| 2 |
Alibaba
BABA
|
+$122M |
| 3 |
IAC Inc
IAC
|
+$111M |
| 4 |
Microsoft
MSFT
|
+$110M |
| 5 |
Fastly
FSLY
|
+$91.7M |
Sector Composition
| 1 | Technology | 23.49% |
| 2 | Healthcare | 12.99% |
| 3 | Consumer Discretionary | 12.41% |
| 4 | Financials | 12.09% |
| 5 | Communication Services | 9.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
PDLI
2576
DELISTED
PDL BioPharma, Inc.
PDLI
| $73K | ﹤0.01% |
23,284
-4,588
| -16% | -$14.4K |
|
2577
Johnson Outdoors
JOUT
$420M
| $72K | ﹤0.01% |
888
-251
| -22% | -$20.4K |
|
2578
Construction Partners
ROAD
$7.01B
| $72K | ﹤0.01% |
3,927
+9
| +0.2% | +$165 |
|
2579
VirnetX
VHC
$74.6M
| $72K | ﹤0.01% |
679
-139
| -17% | -$14.7K |
|
2580
AnaptysBio
ANAB
$649M
| $71K | ﹤0.01% |
4,783
-931
| -16% | -$13.8K |
|
2581
Protagonist Therapeutics
PTGX
$3.71B
| $71K | ﹤0.01% |
3,616
-106
| -3% | -$2.08K |
|
|
DOYU
2582
DouYu International Holdings
DOYU
$242M
| $70K | ﹤0.01% |
+532
| New | +$70K |
|
2583
First Community Bankshares
FCBC
$691M
| $70K | ﹤0.01% |
3,850
-671
| -15% | -$12.2K |
|
2584
Green Brick Partners
GRBK
$3.28B
| $70K | ﹤0.01% |
4,298
-1,105
| -20% | -$18K |
|
2585
Peoples Bancorp
PEBO
$1.09B
| $70K | ﹤0.01% |
3,661
-688
| -16% | -$13.2K |
|
2586
Impinj
PI
$5.34B
| $70K | ﹤0.01% |
2,681
-700
| -21% | -$18.3K |
|
2587
TherapeuticsMD
TXMD
$12.8M
| $70K | ﹤0.01% |
892
-1,324
| -60% | -$104K |
|
|
BCEL
2588
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
| $70K | ﹤0.01% |
4,976
+1,524
| +44% | +$21.4K |
|
|
ACRE
2589
Ares Commercial Real Estate
ACRE
$265M
| $69K | ﹤0.01% |
7,518
-1,424
| -16% | -$13.1K |
|
2590
First Foundation Inc
FFWM
$497M
| $69K | ﹤0.01% |
5,300
-1,767
| -25% | -$23K |
|
2591
GrowGeneration
GRWG
$92.6M
| $69K | ﹤0.01% |
4,293
-375
| -8% | -$6.03K |
|
|
HOME
2592
DELISTED
At Home Group Inc.
HOME
| $69K | ﹤0.01% |
4,611
-1,660
| -26% | -$24.8K |
|
2593
CEL-SCI Corp
CVM
$67.7M
| $68K | ﹤0.01% |
180
-44
| -20% | -$16.6K |
|
2594
Zymeworks
ZYME
$1.24B
| $68K | ﹤0.01% |
1,460
| – | – |
|
|
AMK
2595
DELISTED
AssetMark Financial Holdings, Inc.
AMK
| $67K | ﹤0.01% |
3,069
-632
| -17% | -$13.8K |
|
2596
Copel
ELP
$6.91B
| $66K | ﹤0.01% |
15,003
| – | – |
|
2597
Kiniksa Pharmaceuticals
KNSA
$2.74B
| $66K | ﹤0.01% |
4,291
+29
| +0.7% | +$446 |
|
2598
Purple Innovation
PRPL
$116M
| $66K | ﹤0.01% |
2,652
+308
| +13% | +$7.67K |
|
2599
Prothena Corp
PRTA
$454M
| $66K | ﹤0.01% |
6,649
-1,387
| -17% | -$13.8K |
|
2600
AdaptHealth
AHCO
$1.29B
| $65K | ﹤0.01% |
2,992
+1,696
| +131% | +$36.8K |
|